Genopathy
Gene-Disorder Association · Article
Gene
ALK
ALK Receptor Tyrosine Kinase
Manually curatedApproved treatment annotated
Association Review

In brief

The association between ALK (ALK Receptor Tyrosine Kinase) and Lung Non-Small Cell Carcinoma is reported, with clinical genetic testing available.

Sources 1
Clinical variants 0
Symptoms 0
Compounds 24
Trials 1,973of 10,040 via ALK compounds
Publications 13
01
At a glance

Association overview

A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.

Request access
02
Provenance

Evidence and sources

1 source

Every contributing database and publication behind this association, with evidence type, strength, accessions and deep links.

Request access
03
ALK

The gene

3 source summaries

A gene summary alongside the source descriptions it was distilled from.

Request access
04
Lung Non-Small Cell Carcinoma

The disorder

6 database identifiers

The disorder’s summary, prevalence, aliases and cross-reference identifiers (OMIM, Orphanet, MONDO, ICD-10, MedGen).

Request access
05
Mechanism overlap

Shared mechanisms

1 shared pathway

Biological pathways and phenotype concepts shared by the gene and the disorder, with supporting publications.

Request access
06
Interventions

Therapeutics

24 compounds & drugs

Gene-targeting drugs and associated compounds, with class, approval status, mechanism, indications and trials.

Request access
07
Human studies

Clinical trials

10,040 clinical trials

Clinical trials reached through the pair’s compounds, keeping disorder-targeting trials separate from other indications.

Request access
08
Literature

Reading

13 publications

Publications linking the gene and the disorder, with title, authors, journal, year and citation metrics.

Request access
09
Provenance

References & sources

22 references

Every source and publication cited across this dossier, as one numbered reference list.

Request access